Cerapedics’ i-FACTOR Demonstrates 98.6% Fusion Rate
i-FACTOR is the only spinal bone graft powered by P-15 Osteogenic Cell Binding Peptide, with a precise bone-building mechanism....
i-FACTOR is the only spinal bone graft powered by P-15 Osteogenic Cell Binding Peptide, with a precise bone-building mechanism....
CERAMENT G has previously received breakthrough device designation for the indication's bone infection and trauma....
OsteoCove bioactive synthetic graft has application in a wide range of spine and orthopedic procedures....
QuickDraw uses a small MIS or percutaneous incision to excise precise quantities of morselized autograft bone. ...
The IDE Study will be conducted for the safety and efficacy for the treatment of knee osteoarthritis compared to saline....
NovaBone Products has launched a first foot and ankle-specific syringe delivery system for its bioactive glass....
The FDA 510(k) clearance allows surgeons to use OssDsign Catalyst on-label in any interbody cage cleared for use with synthetic...
OssDsign Catalyst is a nanosynthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion....
The PROPEL registry was initiated in March 2022 to gather real-world data from patients who have been treated with OssDsign...
CartiHeal announced the first commercial implantation of Agili-C in the U.S. The Agili-C implant features a bi-phasic design that supports both...
As a guest member you get access to more articles and webinars every month.
We’ll send a recovery link to your email.
Return to Homepage